Page last updated: 2024-11-06

3,3',5-triiodothyroacetic acid and Osteosarcoma

3,3',5-triiodothyroacetic acid has been researched along with Osteosarcoma in 1 studies

tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
" In the dose-response studies, a biphasic increase in medium IGF-I was observed in both cells and limb bones, with peak stimulatory concentrations of 10(-8) M for T3 and 10(-7) M for T4 in both systems."1.29Thyroid hormones increase insulin-like growth factor I content in the medium of rat bone tissue. ( Caplice, MD; Khanna, V; Lakatos, P; Stern, PH, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lakatos, P1
Caplice, MD1
Khanna, V1
Stern, PH1

Other Studies

1 other study available for 3,3',5-triiodothyroacetic acid and Osteosarcoma

ArticleYear
Thyroid hormones increase insulin-like growth factor I content in the medium of rat bone tissue.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1993, Volume: 8, Issue:12

    Topics: Animals; Bone and Bones; Bone Resorption; Culture Media; Culture Techniques; Dose-Response Relations

1993